How long does it take for subcutaneous (SQ) testosterone to work?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Onset of Action for Subcutaneous Testosterone

Subcutaneous testosterone begins raising serum testosterone levels within the first week of administration, with clinical symptom improvement typically assessed at 3 to 6 months after treatment initiation.

Timeline for Biochemical and Clinical Effects

Immediate Pharmacokinetics (First Week)

  • Serum testosterone levels rise within days after the first injection 1
  • For testosterone enanthate/cypionate SC: Peak testosterone levels occur at approximately 8 days after injection 2
  • Steady-state testosterone concentrations are typically achieved by week 6 of weekly dosing 3

Clinical Monitoring Timeline

According to Endocrine Society guidelines, the structured approach to assessing testosterone "working" is 4:

Initial Assessment (3-6 months):

  • Evaluate symptom response at 3 to 6 months after treatment initiation
  • Check testosterone levels at 3 to 6 months to ensure mid-normal range achievement
  • This is when you assess whether symptoms have responded to treatment

Specific Clinical Effects by Timeline:

  • Libido improvement: May begin within weeks but formally assessed at 3-6 months 4
  • Menstrual cessation (in transgender patients): Average 2.9 months, with 85% achieving cessation by 6 months 5
  • Masculinizing effects: Progressive over first 6 months 6
  • Energy/vitality: Assessed at 3-6 months, though effects are modest 7

Pharmacokinetic Considerations for SC Route

The subcutaneous route has distinct absorption characteristics 2, 3:

  • Later peak compared to IM (8 days vs 3.3 days for testosterone undecanoate)
  • More stable levels with less peak-trough variation
  • Comparable bioavailability to intramuscular administration
  • Weekly dosing (50-100 mg testosterone enanthate) maintains steady levels 3, 8

Important Clinical Caveats

What "working" means depends on the outcome:

  • Biochemical normalization: 1-2 weeks for testosterone levels to rise
  • Symptom improvement: 3-6 months for formal assessment
  • Sexual function: Variable, assessed at 3-6 months
  • Physical changes: Progressive over months

Common pitfall: Patients may expect immediate symptom relief. Set realistic expectations that while testosterone levels normalize quickly, clinical symptom improvement requires 3-6 months of therapy before determining efficacy 4, 9.

Monitoring approach 4:

  • Check testosterone levels at 3-6 months (not earlier for dose adjustment)
  • Assess clinical response at 3-6 months
  • Adjust dosing based on both levels AND symptom response
  • For SC testosterone enanthate: measure levels at any time after 1 week of treatment

The evidence shows SC testosterone is equally effective to IM administration, with 92.7% of patients achieving normal testosterone ranges by week 12 3, and comparable clinical effects between routes 6, 10.

References

Research

Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option.

The Journal of clinical endocrinology and metabolism, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.